Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy.
Saved in:
| Title: | Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy. |
|---|---|
| Authors: | Koll L; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Lourens HJ; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Marsman G; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., de Haan S; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Niki T; Department of Immunology, Kagawa University, Takamatsu, Kagawa, Japan., Huls GA; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Bremer E; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Wiersma VR; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Jun 26; Vol. 16, pp. 1601235. Date of Electronic Publication: 2025 Jun 26 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1601235 |
